National Health Investors (NHI) EBIT (2009 - 2019)

National Health Investors has reported EBIT for 11 years, with the latest figure at $42.8 million in Q3 2019.

• For the quarter ending Q3 2019, EBIT rose 4.33% year-over-year to $42.8 million; the trailing twelve-month figure through Sep 2019 stood at $159.4 million (up 1.15% YoY), and the FY2019 full-year result was $217.6 million, up 6.59% from the prior year.
• EBIT for Q3 2019 stood at $42.8 million, up from $40.0 million in the prior quarter.
• The five-year high for EBIT was $46.4 million in Q4 2016, with the low at $18.6 million in Q2 2016.
• Historically, EBIT has averaged $37.8 million across 5 years, with a median of $39.2 million in 2018.
• Annual changes were most pronounced in 2016 — EBIT sank 54.63% — and 2017, when it soared 106.13%.
• National Health Investors' EBIT stood at $42.1 million in 2015, then rose by 10.22% to $46.4 million in 2016, then dropped by 14.64% to $39.6 million in 2017, then gained by 3.52% to $41.0 million in 2018, then rose by 4.33% to $42.8 million in 2019.
• The last three EBIT figures came in at $42.8 million (Q3 2019), $40.0 million (Q2 2019), and $35.7 million (Q1 2019), per Business Quant data.